Reliant AI, a Montreal, Canada- and Berlin, Germany-based provider of gen AI-powered data analytics software, raised $11.3M in Seed funding.
The round was led by Tola Capital and Inovia Capital, with participation from angel investor Mike Volpi.
The company intends to use the funds to hire engineering talent to expand its technology investment and presence in Europe and North America.
Founded by Karl Moritz Hermann, Marc Bellemare and Richard Schlegel, Reliant AI is a provider of genAI-powered data analytics software that accelerates secondary research in biopharma. Its first product, Reliant Tabular, is an AI workbench that helps life science analysts find scientific evidence for their decisions through automated systematic reviews, asset scans, comprehensive analyses, and a customizable data platform.
Features of Reliant Tabular include:
- Proprietary ML models optimized to be experts in biopharma topics
- Comprehensive approach to fact-finding – maximizing recall so that nothing gets missed
- User interface that makes it quick and easy to reconcile generated results with ground truth evidence
- Answers in a report-ready format so that teams can collaborate on analyses
The solutions is attracting significant interest across key business segments in the biopharma industry.
FinSMEs
20/08/2024